日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Efficacy of Ephedrine Alkaloids-Free Ephedra Herb Extract (EFE) for Mild COVID-19: A Double-Blind, Placebo-Controlled, Randomized Comparative Trial

不含麻黄碱生物碱的麻黄草药提取物(EFE)治疗轻症COVID-19的安全性和有效性:一项双盲、安慰剂对照、随机比较试验

Odaguchi, Hiroshi; Hyuga, Sumiko; Sekine, Mariko; Michimae, Hirofumi; Hyuga, Masashi; Uchiyama, Nahoko; Uema, Masashi; Kumagai, Yuji; Suzuki, Yusuke; Nabeshima, Shigeki; Omagari, Norio; Doi, Yohei; Yamaoka, Kunihiro; Miyazaki, Koji; Fuji, Susumu; Umezawa, Yoshihiro; Kodera, Shiho; Nagashima, Hirotaka; Hirose, Wataru; Goda, Yukihiro

Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy

急性加重预示着特发性间质性肺炎和接受细胞毒性化疗的晚期肺癌患者预后不良。

Miyamoto, Atsushi; Michimae, Hirofumi; Nakahara, Yasuharu; Akagawa, Shinobu; Nakagawa, Kazuhiko; Minegishi, Yuji; Ogura, Takashi; Hontsu, Shigeto; Date, Hiroshi; Takahashi, Kazuhisa; Homma, Sakae; Kishi, Kazuma

A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer

一项回顾性研究,探讨高剂量紫杉醇和卡铂联合贝伐单抗一线治疗晚期上皮性卵巢癌的疗效

Komazaki, Hiromi; Takahashi, Kazuaki; Tanabe, Hiroshi; Shoburu, Yuichi; Kamii, Misato; Tsuda, Akina; Saito, Motoaki; Yamada, Kyosuke; Takano, Hirokuni; Michimae, Hirofumi; Okamoto, Aikou

Melanin-concentrating hormone receptor 1 is discarded by exosomes after internalization

黑色素浓缩激素受体 1 在内化后被外泌体丢弃

Ryohei Yamada, Momoka Michimae, Akie Hamamoto, Hiroshi Takemori

Bayesian parametric estimation based on left-truncated competing risks data under bivariate Clayton copula models

基于左截断竞争风险数据的贝叶斯参数估计,采用双变量 Clayton copula 模型

Michimae, Hirofumi; Emura, Takeshi; Miyamoto, Atsushi; Kishi, Kazuma

Effect of Acid Suppressants on Non- Helicobacter pylori Helicobacters Within Parietal Cells

酸抑制剂对胃壁细胞内非幽门螺杆菌的影响

Masahiko Nakamura, Futa Murasato, Anders Øverby, Yosuke Kodama, Hirofumi Michimae, Kazuki Sasaki, Bram Flahou, Freddy Haesebrouck, Somay Y Murayama, Shinichi Takahashi, Masayuki Uchida, Hidekazu Suzuki, Hidenori Matsui

Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial

一项随机 III 期试验比较了聚乙二醇化脂质体阿霉素 (PLD) 50 mg/m² 与 40 mg/m² 在铂类耐药和铂类难治性卵巢癌患者中的疗效:JGOG 3018 试验

Motohashi, Takashi; Yabuno, Akira; Michimae, Hiroshi; Ohishi, Tetsuro; Nonaka, Miwa; Takano, Masashi; Nishio, Shin; Fujiwara, Hiroyuki; Fujiwara, Keiichi; Kondo, Eiji; Sugiyama, Toru; Tabata, Tsutomu

Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical Trial

紫杉烷类联合铂类方案与多柔比星联合顺铂方案作为子宫内膜癌高危进展患者辅助化疗的疗效比较:一项随机临床试验

Nomura, Hiroyuki; Aoki, Daisuke; Michimae, Hirofumi; Mizuno, Mika; Nakai, Hidekatsu; Arai, Masahide; Sasagawa, Motoi; Ushijima, Kimio; Sugiyama, Toru; Saito, Motoaki; Tokunaga, Hideki; Matoda, Maki; Nakanishi, Toru; Watanabe, Yoh; Takahashi, Fumiaki; Saito, Toshiaki; Yaegashi, Nobuo

Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy

艾立布林和奥拉帕尼联合治疗I/II期研究中三阴性乳腺癌患者的基因改变

Shimomura, Akihiko; Yonemori, Kan; Yoshida, Masayuki; Yoshida, Teruhiko; Yasojima, Hiroyuki; Masuda, Norikazu; Aogi, Kenjiro; Takahashi, Masato; Naito, Yoichi; Shimizu, Satoru; Nakamura, Rikiya; Hamada, Akinobu; Michimae, Hirofumi; Hashimoto, Jun; Yamamoto, Harukaze; Kawachi, Asuka; Shimizu, Chikako; Fujiwara, Yasuhiro; Tamura, Kenji

Photo-induced semimetallic states realised in electron-hole coupled insulators

在电子-空穴耦合绝缘体中实现光致半金属态

Okazaki, Kozo; Ogawa, Yu; Suzuki, Takeshi; Yamamoto, Takashi; Someya, Takashi; Michimae, Shoya; Watanabe, Mari; Lu, Yangfan; Nohara, Minoru; Takagi, Hidenori; Katayama, Naoyuki; Sawa, Hiroshi; Fujisawa, Masami; Kanai, Teruto; Ishii, Nobuhisa; Itatani, Jiro; Mizokawa, Takashi; Shin, Shik